BCM
OPGN

Bayesian Capital Management’s OpGen, Inc OPGN Stock Holding History

Bayesian Capital Management’s Portfolio OPGN Stock Details OPGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-240
Closed -$120K – 695
2021
Q1 		$120K Buy
+240
New +$122K 0.03% 487

Other funds holding OPGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Bayesian Capital Management's OPGN Position: Q2 2021 in Review

Bayesian Capital Management sold out of OpGen, Inc (OPGN) in Q2 2021, closing a stake of 240 shares — an estimated $120K sold.

Bayesian Capital Management first reported a position in OPGN in Q1 2021 and held it in 1 quarter. The position peaked at $120K in Q1 2021. 27 funds tracked by Wall St. Rank hold OPGN as of Q2 2021.

  • Bayesian Capital Management reported no remaining OpGen, Inc position as of Q2 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 240 OpGen, Inc shares in Q2 2021, an estimated $120K.
  • Bayesian Capital Management first reported a position in OpGen, Inc in Q1 2021 and held it in 1 quarter.
  • Bayesian Capital Management's OpGen, Inc position peaked at $120K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held OpGen, Inc as of Q2 2021.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.